Cite
MLA Citation
Jingyang Li et al.. “Real-world cost–effectiveness of infliximab for moderate-to-severe rheumatoid arthritis in a medium-sized city of China.” Journal of comparative effectiveness research, vol. 6, 2017, pp. 205–218. http://access.bl.uk/ark:/81055/vdc_100154509329.0x000009